Artificial Intelligence
The Intelligent Leader Podcast Explores The Future Of Enterprise AI In Life Sciences With Astrazenecas Kabir Patel
Share
Exploring the shift toward autonomous systems and their real-world impact on pharma and enterprise tech.
Drawing from his extensive experience leading technology functions at Oracle, Thomson Reuters, and now at one of the world’s largest pharmaceutical companies, Kabir shares timely insights on how life sciences enterprises are adapting to the transformative potential of AI. The episode, unpacks the real-world implications of shifting from AI that supports tasks to systems that act, reason, and learn independently.
“Agentic AI isn’t just about automation—it’s about autonomy,” says Kabir. “In life sciences, this means building intelligent systems that can make contextual decisions, recover from failures, and adapt in real-time, dramatically improving operational resilience.”
Listeners will gain practical perspectives on the rise of “self-healing” AI systems within pharma’s supply chains—where AI agents proactively identify issues, simulate outcomes, and autonomously resolve disruptions. However, the conversation emphasizes that achieving this level of autonomy requires organizations to first build foundational capabilities through assistive AI pilots in functions like procurement, HR, or IT.
Kabir also outlines a roadmap for scaling agentic AI responsibly, highlighting the importance of data quality, cultural readiness, robust AIOps infrastructure, and a fundamental mindset shift from standardized processes to adaptive workflows. As enterprise tech providers race to embed agentic features into their platforms, companies must make strategic decisions about what to build, what to buy, and where to partner.
“Agentic AI is already reshaping how global enterprises operate—it’s not a future concept, it’s a present imperative,” says host Shashank Garg. “This episode offers leaders a framework to not only understand the distinction between assistive and agentic AI, but to chart their journey toward adoption.”
Listen to the full episode to discover how AstraZeneca and other global enterprises are preparing for the next era of intelligent systems.
Shanthi Srinivasan
InfoCeptsLLC
+1 917-666-6271
email us here
Visit us on social media:
LinkedIn
Instagram
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Frequently Asked Questions
What is Agentic AI?
Agentic AI refers to intelligent systems that can act, reason, and learn independently, going beyond simple automation.
How is Agentic AI impacting the Pharma Industry?
Agentic AI is enabling self-healing AI systems in pharma supply chains, improving operational resilience by proactively identifying and resolving disruptions.
What are the key considerations for scaling Agentic AI responsibly?
Scaling Agentic AI requires data quality, cultural readiness, robust AIOps infrastructure, and a shift from standardized processes to adaptive workflows.
First published on Tue, May 27, 2025
Enjoyed what you read? Great news – there’s a lot more to explore!
Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!
Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.
Head to the TechDogs homepage to Know Your World of technology today!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Loading comments...
